Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept

被引：0
|
作者：
V. Bagalas
I. Kioumis
P. Argyropoulou
D. Patakas
机构：
[1] Aristotle University of Thessaloniki Medical School–“G. Papanikolaou” Hospital,Department of Pulmonary Disease
来源：
Clinical Rheumatology | 2007年 / 26卷
关键词：
Etanercept; Rheumatoid arthritis; TNF-α antagonists; Visceral leishmaniasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-α (TNF-α) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-α antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.
引用
收藏
页码：1344 / 1345
页数：1
相关论文
共 50 条
  • [1] Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
    Bagalas, V.
    Kioumis, I.
    Argyropoulou, P.
    Patakas, D.
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (08) : 1344 - 1345
  • [2] Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab
    Bassetti, M.
    Pizzorni, C.
    Gradoni, L.
    Del Bono, V.
    Cutolo, M.
    Viscoli, C.
    [J]. RHEUMATOLOGY, 2006, 45 (11) : 1446 - 1448
  • [3] Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab
    Fabre, S
    Gibert, C
    Lechiche, C
    Dereure, J
    Jorgensen, C
    Sany, J
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 891 - 892
  • [4] An Atypical Presentation of Visceral Leishmaniasis Infection in a Patient With Rheumatoid Arthritis Treated With Infliximab
    Kritikos, Konstantinos
    Haritatos, Evangelos
    Tsigkos, Stelios
    Gounari, Panagiota
    Skrapari, Ioanna
    Gounaris, Theodore
    Sioula, Evangelia
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (01) : 38 - 39
  • [5] Visceral Leishmaniasis in a Rheumatoid Arthritis Patient Treated With Methotrexate
    Karagiannidis, Grigorios S.
    Mantzourani, Marina
    Meletis, John
    Anastasopoulou, Amalia N.
    Vaiopoulos, George A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (01) : 59 - 59
  • [6] Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate
    Loarce-Martos, Jesus
    Garrote-Corral, Sandra
    Gioia, Francesca
    Bachiller-Corral, Javier
    [J]. REUMATOLOGIA CLINICA, 2019, 15 (06): : E130 - E132
  • [7] Comment on "Visceral Leishmaniasis in a Rheumatoid Arthritis Patient Treated With Methotrexate"
    Guirao-Arrabal, Emilio
    Garcia-Olid, Beatriz
    Munoz-Lopez, Carlos
    Fernandez de la Puebla-Gimenez, Rafael Angel
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (03) : 165 - 165
  • [8] Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept
    Ruffer, Nikolas
    Tomas, Nicola M.
    Schmiedel, Stefan
    Jordan, Sabine
    Koetter, Ina
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (03): : 240 - 243
  • [9] Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: A case description and literature review
    Moreno, Diego
    Martinez, Pedro
    Berbegal, Juan
    Femenia, Miguel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (04): : 261 - 262
  • [10] Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Oishi, Kyosuke
    Kitajima, Shinji
    Wada, Takashi
    Takehara, Kazuhiko
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (05) : 700 - 701
12345